| Primary |
| Renal Transplant |
20.8% |
| Product Used For Unknown Indication |
15.8% |
| Prophylaxis Against Transplant Rejection |
13.8% |
| Drug Use For Unknown Indication |
12.2% |
| Liver Transplant |
4.8% |
| Systemic Lupus Erythematosus |
4.2% |
| Prophylaxis Against Graft Versus Host Disease |
4.1% |
| Hypertension |
3.7% |
| Immunosuppression |
3.2% |
| Transplant Rejection |
2.1% |
| Heart Transplant |
2.1% |
| Myasthenia Gravis |
1.9% |
| Graft Versus Host Disease |
1.8% |
| Prophylaxis |
1.8% |
| Lupus Nephritis |
1.6% |
| Infection Prophylaxis |
1.5% |
| Nephrotic Syndrome |
1.4% |
| Antifungal Prophylaxis |
1.2% |
| Transplant |
1.1% |
| Lung Transplant |
0.8% |
|
| Death |
35.7% |
| Transplant Rejection |
17.5% |
| Vomiting |
5.0% |
| White Blood Cell Count Decreased |
4.3% |
| Kidney Transplant Rejection |
3.4% |
| Cerebrovascular Accident |
3.2% |
| Renal Failure |
3.2% |
| Disease Progression |
2.9% |
| Sepsis |
2.8% |
| Thrombotic Microangiopathy |
2.7% |
| Renal Impairment |
2.6% |
| Pneumonia |
2.5% |
| Weight Decreased |
2.2% |
| Systemic Lupus Erythematosus |
2.1% |
| Respiratory Failure |
1.8% |
| Urinary Tract Infection |
1.7% |
| Aplasia Pure Red Cell |
1.6% |
| Diarrhoea |
1.6% |
| Focal Segmental Glomerulosclerosis |
1.6% |
| Myocardial Infarction |
1.5% |
|
| Secondary |
| Renal Transplant |
34.0% |
| Prophylaxis Against Transplant Rejection |
11.5% |
| Drug Use For Unknown Indication |
9.7% |
| Product Used For Unknown Indication |
6.5% |
| Hypertension |
5.2% |
| Prophylaxis |
5.2% |
| Heart Transplant |
4.8% |
| Immunosuppression |
4.2% |
| Liver Transplant |
3.4% |
| Systemic Lupus Erythematosus |
2.7% |
| Lung Transplant |
2.5% |
| Prophylaxis Against Graft Versus Host Disease |
1.8% |
| Transplant Rejection |
1.4% |
| Immunosuppressant Drug Therapy |
1.3% |
| Cytomegalovirus Infection |
1.2% |
| Infection Prophylaxis |
1.1% |
| Diabetes Mellitus |
1.0% |
| Behcet's Syndrome |
0.9% |
| Bone Marrow Transplant |
0.9% |
| Lupus Nephritis |
0.8% |
|
| Vomiting |
11.1% |
| White Blood Cell Count Decreased |
10.4% |
| Urinary Tract Infection |
6.9% |
| Pyrexia |
6.7% |
| Renal Impairment |
5.8% |
| Sepsis |
5.5% |
| Neutropenia |
5.1% |
| Renal Failure |
5.1% |
| Transplant Rejection |
5.1% |
| Thrombotic Microangiopathy |
4.8% |
| Weight Decreased |
4.5% |
| White Blood Cell Count Increased |
4.3% |
| Thrombocytopenia |
3.7% |
| Pneumonia |
3.5% |
| Septic Shock |
3.3% |
| Cytomegalovirus Infection |
3.0% |
| Viral Infection |
3.0% |
| Osteoporosis |
2.8% |
| Diarrhoea |
2.7% |
| Renal Failure Acute |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.0% |
| Renal Transplant |
15.4% |
| Drug Use For Unknown Indication |
12.3% |
| Prophylaxis Against Transplant Rejection |
7.5% |
| Hypertension |
4.9% |
| Immunosuppression |
4.1% |
| Nuclear Magnetic Resonance Imaging |
3.3% |
| Prophylaxis |
3.3% |
| Liver Transplant |
3.0% |
| Heart Transplant |
2.9% |
| Pain |
2.7% |
| Diabetes Mellitus |
1.6% |
| Systemic Lupus Erythematosus |
1.6% |
| Angiogram |
1.5% |
| Lung Transplant |
1.5% |
| Renal Failure Chronic |
1.3% |
| Depression |
1.1% |
| Pulmonary Arterial Hypertension |
1.0% |
| Immunosuppressant Drug Therapy |
1.0% |
| Anaemia |
1.0% |
|
| Vomiting |
12.2% |
| Death |
8.7% |
| Pyrexia |
6.5% |
| Weight Decreased |
6.2% |
| Renal Failure Acute |
5.3% |
| Transplant Rejection |
5.3% |
| Therapeutic Response Decreased |
5.1% |
| Kidney Transplant Rejection |
4.9% |
| Thrombocytopenia |
4.9% |
| Renal Failure |
4.7% |
| White Blood Cell Count Decreased |
4.5% |
| Pregnancy |
4.3% |
| Sepsis |
4.1% |
| Pneumonia |
4.0% |
| Renal Impairment |
4.0% |
| Drug Ineffective |
3.3% |
| Urinary Tract Infection |
3.3% |
| Skin Tightness |
2.9% |
| Thrombotic Microangiopathy |
2.9% |
| Weight Increased |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
25.4% |
| Prophylaxis Against Transplant Rejection |
10.7% |
| Renal Transplant |
8.5% |
| Pyrexia |
7.9% |
| Hypertension |
7.3% |
| Immunosuppressant Drug Therapy |
6.8% |
| Immunosuppression |
6.8% |
| Bone Marrow Conditioning Regimen |
3.4% |
| Anxiety |
2.8% |
| Depression |
2.8% |
| Lung Transplant |
2.8% |
| Dyspepsia |
2.3% |
| Gastric Disorder |
2.3% |
| Infection Prophylaxis |
1.7% |
| Liver Transplant |
1.7% |
| Prostate Cancer |
1.7% |
| Renal Lymphocele |
1.7% |
| Epstein-barr Virus Infection |
1.1% |
| Gastritis |
1.1% |
| Gout |
1.1% |
|
| Drug Interaction |
14.3% |
| Graft Versus Host Disease |
14.3% |
| Wrong Technique In Drug Usage Process |
11.9% |
| Fatigue |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Sjogren's Syndrome |
4.8% |
| Somnolence |
4.8% |
| Staphylococcal Infection |
4.8% |
| Tremor |
4.8% |
| Delirium |
2.4% |
| Haemoglobin Decreased |
2.4% |
| Liver Disorder |
2.4% |
| Pulmonary Tuberculosis |
2.4% |
| Renal Failure Acute |
2.4% |
| Renal Impairment |
2.4% |
| Restlessness |
2.4% |
| Splenomegaly |
2.4% |
| Transplant Rejection |
2.4% |
| Ventricular Extrasystoles |
2.4% |
| Viral Infection |
2.4% |
|
